MJBizCon Interviews: Alex Halperin: Editor: WeedWeek
Latest News
Definium Doses First Patient in Second Phase 3 LSD-Based Trial
NEW YORK – Definium Therapeutics Inc. has taken another step forward in its late-stage testing of a psychedelic-derived treatment for major depressive disorder. The company announced that the first participant received a dose in the ...
Glass House Brands Reports Q1 2026 Financial Results
LONG BEACH – Glass House Brands Inc. released its first-quarter earnings for 2026, showing revenue slightly ahead of internal expectations but down from the year-ago period, with profitability pressured by higher costs and soft wholesale ...
Planet 13 Reports Q1 2026 Financial Results
LAS VEGAS – Planet 13 Holdings Inc. released its first-quarter 2026 financials, reflecting the effects of substantial operational changes and declines in top-line figures, yet showcasing margin gains and cost controls as indications of progress ...


































